5Tanaka H,Tsukuma H,Kasahara A,et al.Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C:a retrospective cohort study of 738 patients.Int J Cancer,2000,87(5):741.
6Mitsuda A,Suou T,Ikuta Y,et al.Changes in serum tissue inhibitor of matrix metalloproteinase-1 after interferon alpha treatment in chronic hepatitis C.J Hepatol,2000,32(4):666.
7Trepo C.Hepatitis research unit and liver unit,hotel Dieu hospital,Lyon,France.J Viral Hepatitis,2000,7(4):250.
5[1]Craxi A, Camma C, Giunta M.Definition of response to antiviral therapy in chronic hepatitis C[J].J Hepatol, 1999, 31(suppl): 160.
6[2]Tanaka H, Tsukuma H, Kasahara A, et al.Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients[J].Int J Cancer, 2000, 87(5): 741.
7[3]Mitsuda A, Suou T, Ikuta Y, et al.Changes in serum tissue inhibitor of matrix metalloproteinase-1 after int-erferon alpha treatment in chronic hepatitis C[J].J He-patol, 2000, 32(4): 666.
8[4]Trepo C.Hepatitis research unit and liver unit, hoteldi-eu hospital, lyon, france[J].J Viral Hepatitis, 2000, 7(4): 250.
9[5]Fallows G, Kaita K, Minuk G, et al.Early changes in hepatitis C virus(HCV) RNA levels predict response to interferon treatment in noncirrhotic HCV patients[J].CanJ Gastroenterol, 2000, 14(suppl B): 30B.
10[6]Hultgren C, Milich DR, Weiland O, et al.The antiviral compound ribavirin modulates the T helper(Th) 1/Th2 subset balance in hepatitis B and C virus-specific immu-ne responses[J].J Gen Viral, 1998, 79(10): 2 381.
